[HTML][HTML] Interpreting global trends in type 2 diabetes complications and mortality
International trends in traditional diabetes complications (cardiovascular, renal, peripheral
vascular, ophthalmic, hepatic or neurological diseases) and mortality rates are poorly …
vascular, ophthalmic, hepatic or neurological diseases) and mortality rates are poorly …
[HTML][HTML] The need for screening, early diagnosis, and prediction of chronic kidney disease in people with diabetes in low-and middle-income countries—a review of …
Chronic kidney disease (CKD) in people with diabetes is becoming an increasing major
public health concern, disproportionately burdening low-and middle-income countries …
public health concern, disproportionately burdening low-and middle-income countries …
[HTML][HTML] Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of …
KL Ong, LK Stafford, SA McLaughlin, EJ Boyko… - The Lancet, 2023 - thelancet.com
Background Diabetes is one of the leading causes of death and disability worldwide, and
affects people regardless of country, age group, or sex. Using the most recent evidentiary …
affects people regardless of country, age group, or sex. Using the most recent evidentiary …
[HTML][HTML] Carotenoids Composition of Green Algae Caulerpa racemosa and Their Antidiabetic, Anti-Obesity, Antioxidant, and Anti-Inflammatory Properties
Green alga Caulerpa racemosa is an underexploited species of macroalgae, even though it
is characterized by a green color that indicates an abundance of bioactive pigments, such as …
is characterized by a green color that indicates an abundance of bioactive pigments, such as …
The role of structural racism and geographical inequity in diabetes outcomes
Diabetes is pervasive, exponentially growing in prevalence, and outpacing most diseases
globally. In this Series paper, we use new theoretical frameworks and a narrative review of …
globally. In this Series paper, we use new theoretical frameworks and a narrative review of …
[HTML][HTML] Diabetes risk and provision of diabetes prevention activities in 44 low-income and middle-income countries: a cross-sectional analysis of nationally …
Background The global burden of diabetes is rising rapidly, yet there is little evidence on
individual-level diabetes prevention activities undertaken by health systems in low-income …
individual-level diabetes prevention activities undertaken by health systems in low-income …
Achievement of guideline recommended diabetes treatment targets and health habits in people with self-reported diabetes in India (ICMR-INDIAB-13): a national …
RM Anjana, R Unnikrishnan, M Deepa… - The Lancet Diabetes & …, 2022 - thelancet.com
Background There is little information on comprehensive diabetes care comprising
glycaemic, lipid, and blood pressure control in India; therefore, we aimed to assess the …
glycaemic, lipid, and blood pressure control in India; therefore, we aimed to assess the …
[HTML][HTML] Dietary Supplementation of Caulerpa racemosa Ameliorates Cardiometabolic Syndrome via Regulation of PRMT-1/DDAH/ADMA Pathway and Gut …
This study evaluated the effects of an aqueous extract of Caulerpa racemosa (AEC) on
cardiometabolic syndrome markers, and the modulation of the gut microbiome in mice …
cardiometabolic syndrome markers, and the modulation of the gut microbiome in mice …
[HTML][HTML] Age-specific population attributable risk factors for all-cause and cause-specific mortality in type 2 diabetes: An analysis of a 6-year prospective cohort study of …
Background The prevalence of type 2 diabetes has increased in both young and old people.
We examined age-specific associations and population attributable fractions (PAFs) of risk …
We examined age-specific associations and population attributable fractions (PAFs) of risk …
[HTML][HTML] Estimated effect of increased diagnosis, treatment, and control of diabetes and its associated cardiovascular risk factors among low-income and middle …
Background Given the increasing prevalence of diabetes in low-income and middle-income
countries (LMICs), we aimed to estimate the health and cost implications of achieving …
countries (LMICs), we aimed to estimate the health and cost implications of achieving …